Navigation Links
AGA unveils latest advances in GI research at DDW 2014
Date:5/2/2014

Chicago, IL (May 2, 2014) International leaders in the fields of gastroenterology and hepatology will gather together for Digestive Disease Week (DDW) 2014, the largest and most prestigious gastroenterology meeting, from May 3 to 6, 2014, at McCormick Place in Chicago, IL. DDW is jointly sponsored by the American Gastroenterological Association (AGA) Institute, the American Association for the Study of Liver Diseases (AASLD), the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT).

AGA researchers will present exciting, cutting-edge data during the meeting that will help change the way physicians diagnose and treat gastrointestinal (GI) disorders. All data presented during DDW is embargoed until the beginning of the presentation or an official DDW press conference, whichever occurs first. A list of press activities is available at http://www.ddw.org/press. Newsroom staff can facilitate interviews with researchers presenting at the sessions highlighted below.

All sessions will be held in McCormick Place (Central Time). For more information on presentations and data being presented, visit http://www.myddw.org.

Plenary Sessions

The 2014 joint ASGE-AGA Presidential Plenary Session will take place on May 4 from 1:30 to 5 p.m. in the Arie Crown Theater.

AGA Institute President, Anil K. Rustgi, MD, AGAF, and his ASGE counterpart have invited noted experts to present on hot topics in gastroenterology and GI endoscopy. Presentations include:

  • "Have We Reached the Top for IBD Therapy?" Gary R. Lichtenstein, MD, Hospital of the University of Pennsylvania, Philadelphia
  • "Pancreatic Cancer: Have We Made Progress?" Andrew D. Rhim, MD, University of Michigan Health System, Ann Arbor
  • "Colorectal Polyps: Is the Resect and Discard Strategy Ready for Primetime?" Pro: Douglas K. Rex, MD, AGAF, Indiana University, Indianapolis; Con: Robert H. Riddell, MD, Mount Sinai Hospital, Toronto, Ontario, Canada
  • "IBS and FODMAP," Lin Chang, MD, AGAF, David Geffen School of Medicine at University of California, Los Angeles
  • "Dietary Effects of the Gut Microbiome," Gary D. Wu, MD, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
  • "C. Difficile Infection and Fecal Microbiota Transplantation," Colleen R. Kelly, MD, Warren Alpert Medical School of Brown University, Providence, RI
  • "HCV Therapy in 2014," David Thomas, MD, MPH, John Hopkins Center for Global Health, Baltimore, MD

AGA will also host a Basic Science Plenary Session on May 4 from 10 to 11:30 a.m. in Room S102ABC.

Late-Breaking Abstract Sessions

Two late breaking abstract sessions will highlight new data accepted for presentation at DDW:

  • Basic science late-breaking abstracts: May 6, 8 to 9:30 a.m., in Room S105A
  • Clinical science late-breaking abstracts: May 6, 10 to 11:30 a.m., Room S102ABC

Scientists present late-breaking abstracts during posters sessions on May 6, 8 a.m. to 5 p.m. ET, South Hall. Researchers will be present at their posters from noon to 2 p.m.

Other exciting data will be presented during DDW, including 61 clinical symposia, 16 research symposia, 10 translational symposia, 10 state-of-the-art lectures, six distinguished abstract plenary sessions, and other committee-sponsored and special sessions on a range of GI topics. Additionally, the AGA Institute will sponsor four curbside consultant sessions. A total of 10 focused research roundtables and focused clinical updates breakfast sessions designed to help participants choose the must-see basic science and clinical research abstracts presented during DDW will occur throughout the meeting.

AGA has also developed special tracks for minority physician-scientists and trainees and young GIs.


'/>"/>

Contact: Rachel Steigerwald
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Related biology news :

1. AGA unveils latest advances in GI research at DDW® 2014
2. Vapor Corp. Unveils E-Cigarette Industrys First Biometric Technology
3. SensoMotoric Instruments Unveils SMI RED-n Consumer Eye Control Technology for Gaming and Computing
4. Hidden layer of genome unveils how plants may adapt to environments throughout the world
5. Brown unveils novel wireless brain sensor
6. Amiigo Unveils Fitness Tracker That Knows What Exercise Youre Performing
7. Synchrotron infrared unveils a mysterious microbial community
8. The Sackler Institute unveils a global research agenda for nutrition science
9. National Geographic unveils new phase of genographic project
10. Rice unveils super-efficient solar-energy technology
11. Genetic Engineering & Biotechnology News unveils Biotech Boulevard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...
(Date:11/29/2016)... France , November 29, 2016 Nearly one ... Continue Reading ... ... is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... ... their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This ... products engineered to radically streamline culture processes, minimize processing time, significantly decrease ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented ... expansion clinical trial for its lead drug candidate, AC0010, at the World Conference ... was to determine the safety, antitumor activity, and recommended phase II dosage of ...
(Date:12/7/2016)... 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") announces ... at the Company,s Annual and Special Meeting. ... place on Thursday, December 15, 2016 at Mount ... EC1040), 4825 Mount Royal Gate SW, Calgary, Alberta ... meeting and management information circular, containing the matters to be ...
Breaking Biology Technology: